Bellerophon Therapeutics Inc (NASDAQ:BLPH)

2.35
Delayed Data
As of Jan 26
 -0.105 / -4.29%
Today’s Change
2.26
Today|||52-Week Range
9.19
-24.35%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$24.1M

Company Description

Bellerophon Therapeutics, Inc. focuses on developing products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline include PH-ILD, PH-COPD and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.

Contact Information

Bellerophon Therapeutics, Inc.
184 Liberty Corner Road
Warren New Jersey 07059
P:(908) 574-4770
Investor Relations:

Employees

Shareholders

Mutual fund holders8.42%
Individual stakeholders29.17%
Other institutional23.97%

Top Executives

Peter FernandesChief Executive, Regulatory & Safety Officer
Parag Suresh ShahVice President-Business Operations
Nicholas LacconaChief Financial & Accounting Officer
Edwin L. ParsleyChief Medical Officer
Martin DekkerVice President-Engineering & Manufacturing